Announcement on Updating Application Documents for Inquiry Response and Prospectus for Private Placement of Shares to Specific Objects

Chempartner Pharmatech Co., Ltd.·June 30, 2026·2 pages

✨ AI Summary

The company received an inquiry letter from the Shenzhen Stock Exchange regarding its private placement of shares. The company has responded and updated its application documents, including the prospectus. The board of directors approved adjustments to the offering price and number of shares. The offering is subject to SZSE review and CSRC registration.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 300149

Securities Abbreviation: Ruizhi Pharmaceutical

Announcement No.: 2026-39

Ruizhi Pharmaceutical Technology Co., Ltd.

Announcement on Updating Application Documents for Inquiry Response and Prospectus for Private Placement of Shares to Specific Objects

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.

Ruizhi Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") received the "Inquiry Letter on the Application for Private Placement of Shares to Specific Objects" (Inquiry Letter [2025] No. 020051) issued by the Shenzhen Stock Exchange (hereinafter referred to as the "SZSE") on September 16, 2025 (hereinafter referred to as the "Inquiry Letter").

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.